Perspectives of women participating in a cervical cancer screening campaign with community-based HPV self-sampling in rural western Kenya: a qualitative study.


Journal

BMC women's health
ISSN: 1472-6874
Titre abrégé: BMC Womens Health
Pays: England
ID NLM: 101088690

Informations de publication

Date de publication:
13 06 2019
Historique:
received: 01 11 2018
accepted: 05 06 2019
entrez: 15 6 2019
pubmed: 15 6 2019
medline: 22 11 2019
Statut: epublish

Résumé

Despite cervical cancer being preventable with effective screening programs, it is the most common cancer and the leading cause of cancer-related death among women in many countries in Africa. Screening involving pelvic examination may not be feasible or acceptable in limited-resource settings. We sought to evaluate women's perspectives on human papillomavirus (HPV) self-sampling as part of a larger trial on cervical cancer prevention implementation strategies in rural western Kenya. We invited 120 women participating in a cluster randomized trial of cervical cancer screening implementation strategies in Migori County, Kenya for in-depth interviews. We explored reasons for testing, experience with and ability to complete HPV self-sampling, importance of clinician involvement during screening, factors and people contributing to screening decision-making, and ways to encourage other women to come for screening. We used validated theoretical frameworks to analyze the qualitative data. Women reported having positive experiences with the HPV self-sampling strategy. The factors facilitating uptake included knowledge and beliefs such as prior awareness of HPV, personal perception of cervical cancer risk, desire for improved health outcomes, and peer and partner encouragement. Logistical and screening facilitators included confidence in the ability to complete HPV self-sampling strategy, proximity to screening sites and feelings of privacy and comfort conducting the HPV self- sampling. The barriers to screening included fear of need for a pelvic exam, fear of disease and death associated with cervical cancer. We classified these findings as capabilities, opportunities and motivations for health behavior using the COM-B framework. Overall, HPV self-sampling was an acceptable cervical cancer screening strategy that seemed to meet the needs of the women in this community. These findings will further inform aspects of implementation, including outreach messaging, health education, screening sites and emphasis on availability and effectiveness of preventative treatment for women who screen positive.

Sections du résumé

BACKGROUND
Despite cervical cancer being preventable with effective screening programs, it is the most common cancer and the leading cause of cancer-related death among women in many countries in Africa. Screening involving pelvic examination may not be feasible or acceptable in limited-resource settings. We sought to evaluate women's perspectives on human papillomavirus (HPV) self-sampling as part of a larger trial on cervical cancer prevention implementation strategies in rural western Kenya.
METHODS
We invited 120 women participating in a cluster randomized trial of cervical cancer screening implementation strategies in Migori County, Kenya for in-depth interviews. We explored reasons for testing, experience with and ability to complete HPV self-sampling, importance of clinician involvement during screening, factors and people contributing to screening decision-making, and ways to encourage other women to come for screening. We used validated theoretical frameworks to analyze the qualitative data.
RESULTS
Women reported having positive experiences with the HPV self-sampling strategy. The factors facilitating uptake included knowledge and beliefs such as prior awareness of HPV, personal perception of cervical cancer risk, desire for improved health outcomes, and peer and partner encouragement. Logistical and screening facilitators included confidence in the ability to complete HPV self-sampling strategy, proximity to screening sites and feelings of privacy and comfort conducting the HPV self- sampling. The barriers to screening included fear of need for a pelvic exam, fear of disease and death associated with cervical cancer. We classified these findings as capabilities, opportunities and motivations for health behavior using the COM-B framework.
CONCLUSIONS
Overall, HPV self-sampling was an acceptable cervical cancer screening strategy that seemed to meet the needs of the women in this community. These findings will further inform aspects of implementation, including outreach messaging, health education, screening sites and emphasis on availability and effectiveness of preventative treatment for women who screen positive.

Identifiants

pubmed: 31196175
doi: 10.1186/s12905-019-0778-2
pii: 10.1186/s12905-019-0778-2
pmc: PMC6567898
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

75

Subventions

Organisme : NCI NIH HHS
ID : R01 CA188428
Pays : United States

Références

Patient Educ Couns. 2015 Jul;98(7):884-9
pubmed: 25858634
Cancer Epidemiol Biomarkers Prev. 2008 Aug;17(8):2163-8
pubmed: 18708409
BMC Cancer. 2017 Dec 06;17(1):826
pubmed: 29207966
BMC Public Health. 2014 Jun 12;14:596
pubmed: 24927941
BMC Res Notes. 2013 Apr 08;6:136
pubmed: 23566436
Eur J Cancer Care (Engl). 2017 Jan;26(1):
pubmed: 26853214
Cancer Med. 2015 Apr;4(4):620-31
pubmed: 25653188
Ethn Health. 2005 Feb;10(1):3-18
pubmed: 15841584
Lancet Oncol. 2008 Oct;9(10):929-36
pubmed: 18805733
Int Nurs Rev. 2008 Mar;55(1):73-80
pubmed: 18275539
Papillomavirus Res. 2017 Dec;4:17-21
pubmed: 29179864
Lancet Glob Health. 2015 Feb;3(2):e85-94
pubmed: 25617202
Asian Pac J Cancer Prev. 2014;15(17):7437-41
pubmed: 25227855
BMC Med Educ. 2006 Mar 01;6:13
pubmed: 16509979
Int J Gynaecol Obstet. 2005 May;89 Suppl 2:S38-45
pubmed: 15823265
IARC Sci Publ. 2011;(162):1-5
pubmed: 21675400
Int J Gynaecol Obstet. 2013 Aug;122(2):118-23
pubmed: 23731506
N Engl J Med. 2009 Apr 2;360(14):1385-94
pubmed: 19339719
J Womens Health (Larchmt). 2017 Jun;26(6):597-599
pubmed: 28414574
JAMA. 2005 Nov 2;294(17):2173-81
pubmed: 16264158
J Community Health. 2015 Aug;40(4):756-61
pubmed: 25677728
Cancer Nurs. 1994 Oct;17(5):395-402
pubmed: 7954387
Sex Transm Dis. 2015 Nov;42(11):607-11
pubmed: 26462184
J AIDS Clin Res. 2015 Jun;6(6):
pubmed: 26457229
Can J Public Health. 2013 Feb 11;104(2):e159-66
pubmed: 23618210
Implement Sci. 2017 Jun 21;12(1):77
pubmed: 28637486
J Multidiscip Healthc. 2015 Mar 18;8:139-46
pubmed: 25834455
Qual Saf Health Care. 2005 Feb;14(1):26-33
pubmed: 15692000
Cancer Causes Control. 2010 Mar;21(3):421-31
pubmed: 19943103
J Obstet Gynaecol. 2002 Jul;22(4):421-2
pubmed: 12521469
Perspect Sex Reprod Health. 2005 Jun;37(2):78-84
pubmed: 15961361
BMC Public Health. 2016 Aug 19;16:832
pubmed: 27538390
Oncologist. 2017 Feb;22(2):173-181
pubmed: 28167567
J Acquir Immune Defic Syndr. 2014 May 1;66 Suppl 1:S130-7
pubmed: 24732817
Implement Sci. 2011 Apr 23;6:42
pubmed: 21513547
J Glob Oncol. 2017 Jan 18;3(5):444-454
pubmed: 29094082
Implement Sci. 2012 Apr 24;7:37
pubmed: 22530986
J Community Health. 2011 Feb;36(1):121-31
pubmed: 20559695
Vaccine. 2012 Nov 20;30 Suppl 4:D1-83, vi
pubmed: 23510764
BMC Health Serv Res. 2014 Aug 06;14:335
pubmed: 25100298
West J Med. 2001 Oct;175(4):231-3
pubmed: 11577044
Int J Gynaecol Obstet. 2018 Apr;141(1):63-69
pubmed: 29197067

Auteurs

Sandra Y Oketch (SY)

Center for Microbiology Research, Kenya Medical Research Institute, P. O. Box 54840 00200, Mbagathi Road, Nairobi, Kenya. sandyvone68@gmail.com.

Zachary Kwena (Z)

Center for Microbiology Research, Kenya Medical Research Institute, P. O. Box 54840 00200, Mbagathi Road, Nairobi, Kenya.

Yujung Choi (Y)

Duke Global Health Institute, Box 90519, 310 Trent Drive, Durham, NC, 27710, USA.

Konyin Adewumi (K)

Duke Global Health Institute, Box 90519, 310 Trent Drive, Durham, NC, 27710, USA.

Michelle Moghadassi (M)

Department of Obstetrics and Gynecology, University of California San Francisco, 550 16th Street, 3749, San Francisco, CA, 94158, USA.

Elizabeth A Bukusi (EA)

Center for Microbiology Research, Kenya Medical Research Institute, P. O. Box 54840 00200, Mbagathi Road, Nairobi, Kenya.
Department of Obstetrics and Gynecology, University of Nairobi, P. O. Box 54840 00200, Nairobi, Kenya.
Department of Obstetrics and Gynecology, Aga Khan University, P. O. Box 30270 00100, Third Avenue, Limuru Rd, Nairobi, Kenya.
Departments of Obstetrics and Gynecology, University of Washington, P. O. Box 356460, Seattle, WA, 98195, USA.

Megan J Huchko (MJ)

Duke Global Health Institute, Box 90519, 310 Trent Drive, Durham, NC, 27710, USA.
Department of Obstetrics and Gynecology, Duke University, Box 90519, 310 Trent Drive, Durham, NC, 27710, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH